Related Experiment Videos

Plasma high density lipoproteins and coronary artery disease

Advances in Myocardiology
|January 1, 1980
PubMed

Insights

High-density lipoprotein (HDL) cholesterol levels are crucial for preventing coronary artery disease (CAD). Lower HDL and reduced lecithin:cholesterol acyltransferase (LCAT) activity are linked to more severe CAD, especially in women.

Area of Science:

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Atherosclerosis Research

Background:

  • Coronary artery disease (CAD) is a major health concern.
  • Plasma lipid profiles are known risk factors for atherosclerosis.
  • The role of high-density lipoprotein (HDL) cholesterol in CAD requires further elucidation.

Purpose of the Study:

  • To investigate the relationship between plasma lipid levels and the presence and extent of coronary artery disease (CAD).
  • To identify key atherosclerosis risk factors contributing to CAD development.
  • To explore the association between lecithin:cholesterol acyltransferase (LCAT) activity and CAD.

Main Methods:

  • Coronary angiography was performed on 102 patients.
  • Plasma lipid profiles, including HDL, LDL, and total cholesterol, were analyzed.
  • Atherosclerosis risk factors and LCAT enzymatic activity were assessed.

Main Results:

  • Patients with CAD had lower HDL cholesterol and higher total and LDL cholesterol compared to those without CAD.
  • HDL cholesterol levels were inversely correlated with the extent of CAD (number of obstructed vessels).
  • Reduced LCAT activity was associated with the presence and extent of CAD.

Conclusions:

  • Elevated HDL cholesterol demonstrates a protective effect against coronary obstructive disease.
  • Decreased HDL cholesterol is a significant determinant of CAD, particularly in females.
  • LCAT may play a role in mobilizing cholesterol from atherosclerotic lesions, contributing to HDL's protective function.

Related Concept Videos